Economic burden of patients with leading cancers in China: a cost-of-illness study
China accounts for 24% of newly diagnosed cancer cases and 30% of cancer-related deaths worldwide. Comprehensive analyses of the economic burden on patients across different cancer treatment phases, based on empirical data, are lacking. This study aims to estimate the financial burden borne by patie...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
27 September 2024
|
| In: |
BMC health services research
Year: 2024, Jahrgang: 24, Pages: 1-13 |
| ISSN: | 1472-6963 |
| DOI: | 10.1186/s12913-024-11514-x |
| Online-Zugang: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/s12913-024-11514-x Verlag, kostenfrei, Volltext: https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-024-11514-x 
|
| Verfasserangaben: | Ziting Wu, Yiwen Yu, Feng Xie, Qiushi Chen, Zhong Cao, Simiao Chen and Gordon G. Liu |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1928493610 | ||
| 003 | DE-627 | ||
| 005 | 20250721111120.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250617s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12913-024-11514-x |2 doi | |
| 035 | |a (DE-627)1928493610 | ||
| 035 | |a (DE-599)KXP1928493610 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wu, Ziting |e VerfasserIn |0 (DE-588)1205037403 |0 (DE-627)1690368896 |4 aut | |
| 245 | 1 | 0 | |a Economic burden of patients with leading cancers in China |b a cost-of-illness study |c Ziting Wu, Yiwen Yu, Feng Xie, Qiushi Chen, Zhong Cao, Simiao Chen and Gordon G. Liu |
| 264 | 1 | |c 27 September 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.06.2025 | ||
| 520 | |a China accounts for 24% of newly diagnosed cancer cases and 30% of cancer-related deaths worldwide. Comprehensive analyses of the economic burden on patients across different cancer treatment phases, based on empirical data, are lacking. This study aims to estimate the financial burden borne by patients and analyze the cost compositions of the leading cancers with the highest number of new cases in China. | ||
| 650 | 4 | |a Cancer costs | |
| 650 | 4 | |a China | |
| 650 | 4 | |a Cost-of-illness | |
| 650 | 4 | |a Treatment phases | |
| 700 | 1 | |a Yu, Yiwen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Xie, Feng |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chen, Qiushi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cao, Zhong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chen, Simiao |e VerfasserIn |0 (DE-588)1138719242 |0 (DE-627)896263061 |0 (DE-576)492659265 |4 aut | |
| 700 | 1 | |a Liu, Gordon G. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC health services research |d London : BioMed Central, 2001 |g 24(2024), Artikel-ID 1135, Seite 1-13 |h Online-Ressource |w (DE-627)331018756 |w (DE-600)2050434-2 |w (DE-576)107014920 |x 1472-6963 |7 nnas |a Economic burden of patients with leading cancers in China a cost-of-illness study |
| 773 | 1 | 8 | |g volume:24 |g year:2024 |g elocationid:1135 |g pages:1-13 |g extent:13 |a Economic burden of patients with leading cancers in China a cost-of-illness study |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12913-024-11514-x |x Resolving-System |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-024-11514-x |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250617 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1138719242 |a Chen, Simiao |m 1138719242:Chen, Simiao |d 910000 |d 912800 |e 910000PC1138719242 |e 912800PC1138719242 |k 0/910000/ |k 1/910000/912800/ |p 6 | ||
| 999 | |a KXP-PPN1928493610 |e 473510559X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1186/s12913-024-11514-x"],"eki":["1928493610"]},"physDesc":[{"noteIll":"Illustrationen","extent":"13 S."}],"relHost":[{"note":["Gesehen am 28.07.2021"],"disp":"Economic burden of patients with leading cancers in China a cost-of-illness studyBMC health services research","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"BMC health services research","title":"BMC health services research"}],"recId":"331018756","origin":[{"publisher":"BioMed Central","dateIssuedDisp":"2001-","dateIssuedKey":"2001","publisherPlace":"London"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"zdb":["2050434-2"],"issn":["1472-6963"],"eki":["331018756"]},"pubHistory":["1.2001 -"],"part":{"text":"24(2024), Artikel-ID 1135, Seite 1-13","pages":"1-13","year":"2024","extent":"13","volume":"24"}}],"title":[{"subtitle":"a cost-of-illness study","title":"Economic burden of patients with leading cancers in China","title_sort":"Economic burden of patients with leading cancers in China"}],"person":[{"display":"Wu, Ziting","role":"aut","family":"Wu","given":"Ziting"},{"family":"Yu","given":"Yiwen","display":"Yu, Yiwen","role":"aut"},{"family":"Xie","given":"Feng","display":"Xie, Feng","role":"aut"},{"display":"Chen, Qiushi","role":"aut","family":"Chen","given":"Qiushi"},{"role":"aut","display":"Cao, Zhong","given":"Zhong","family":"Cao"},{"family":"Chen","given":"Simiao","display":"Chen, Simiao","role":"aut"},{"display":"Liu, Gordon G.","role":"aut","family":"Liu","given":"Gordon G."}],"language":["eng"],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"27 September 2024"}],"name":{"displayForm":["Ziting Wu, Yiwen Yu, Feng Xie, Qiushi Chen, Zhong Cao, Simiao Chen and Gordon G. Liu"]},"recId":"1928493610","note":["Gesehen am 17.06.2025"]} | ||
| SRT | |a WUZITINGYUECONOMICBU2720 | ||